Hepatitis C News and Research

Latest Hepatitis C News and Research

Positive data from Anadys' setrobuvir Phase IIb combination study on genotype 1 HCV

Positive data from Anadys' setrobuvir Phase IIb combination study on genotype 1 HCV

Roundup: N.Y. health insurers seek to keep premium memos secret

Roundup: N.Y. health insurers seek to keep premium memos secret

New robust technique holds promise for identifying trace mutant DNA sequences

New robust technique holds promise for identifying trace mutant DNA sequences

PROLOR receives U.S. patent allowance for CTP-modified interferons

PROLOR receives U.S. patent allowance for CTP-modified interferons

Vertex announces availability of INCIVEK to treat hepatitis C in Canada

Vertex announces availability of INCIVEK to treat hepatitis C in Canada

First Edition: October 11, 2011

First Edition: October 11, 2011

Scripps Research receives NIH grant to determine how HCV induces liver cancer

Scripps Research receives NIH grant to determine how HCV induces liver cancer

ICF wins re-compete contract with Centers For Disease Control And Prevention

ICF wins re-compete contract with Centers For Disease Control And Prevention

Positive results from Biotron's BIT225 Phase 2a trial on HCV

Positive results from Biotron's BIT225 Phase 2a trial on HCV

Pharmasset adds two treatment arms to PSI-7977 ELECTRON trial on HCV

Pharmasset adds two treatment arms to PSI-7977 ELECTRON trial on HCV

VGX International, Inovio partner to co-develop SynCon vaccines for hepatitis B and C infections

VGX International, Inovio partner to co-develop SynCon vaccines for hepatitis B and C infections

Santaris Pharma to report new clinical data from miravirsen Phase 2a study on HCV

Santaris Pharma to report new clinical data from miravirsen Phase 2a study on HCV

Combination therapy improves outcomes for liver cancer patients: Study

Combination therapy improves outcomes for liver cancer patients: Study

Bristol-Myers to present abstracts on research in liver disease at The Liver Meeting 2011

Bristol-Myers to present abstracts on research in liver disease at The Liver Meeting 2011

New analyses from Phase III studies of VICTRELIS to be presented at AASLD 2011

New analyses from Phase III studies of VICTRELIS to be presented at AASLD 2011

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

Patients with chronic hepatitis C less likely to take medications over time

Patients with chronic hepatitis C less likely to take medications over time

Researchers determine structure of RIG-I protein linked with viral infections

Researchers determine structure of RIG-I protein linked with viral infections

Sexually transmitted infection epidemic worries health experts

Sexually transmitted infection epidemic worries health experts

AASLD publishes updated practice guidelines on hepatitis C

AASLD publishes updated practice guidelines on hepatitis C

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.